Enanta Pharmaceuticals
ENTA
#8720
Rank
โ‚ฌ0.20 B
Marketcap
6,94ย โ‚ฌ
Share price
-4.51%
Change (1 day)
-33.93%
Change (1 year)

EPS for Enanta Pharmaceuticals (ENTA)

EPS in 2026 (TTM): -2,07ย โ‚ฌ

According to Enanta Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -2,20ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -2,92ย โ‚ฌ an increase over its 2024 EPS that were of -4,51ย โ‚ฌ.

EPS history for Enanta Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-2,07ย โ‚ฌ-28.86%
2025-2,92ย โ‚ฌ-35.35%
2024-4,51ย โ‚ฌ
2021-4,54ย โ‚ฌ72.92%
2020-2,62ย โ‚ฌ-267.44%
20191,57ย โ‚ฌ-61.35%
20184,06ย โ‚ฌ147.22%
20171,64ย โ‚ฌ-460%
2016-0,46ย โ‚ฌ-114.88%
20153,06ย โ‚ฌ-23.81%
20144,02ย โ‚ฌ-244.12%
2013-2,79ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
6,09ย โ‚ฌ-377.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
4,78ย โ‚ฌ-317.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
5,33ย โ‚ฌ-342.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
14,28ย โ‚ฌ-750.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
0,91ย โ‚ฌ-141.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
4,12ย โ‚ฌ-287.55%๐Ÿ‡บ๐Ÿ‡ธ USA